IL259064A - Compositions comprising il6r antibodies for the treatment of uveitis and macular edema and methods of using same - Google Patents

Compositions comprising il6r antibodies for the treatment of uveitis and macular edema and methods of using same

Info

Publication number
IL259064A
IL259064A IL259064A IL25906418A IL259064A IL 259064 A IL259064 A IL 259064A IL 259064 A IL259064 A IL 259064A IL 25906418 A IL25906418 A IL 25906418A IL 259064 A IL259064 A IL 259064A
Authority
IL
Israel
Prior art keywords
uveitis
compositions
treatment
methods
same
Prior art date
Application number
IL259064A
Other languages
English (en)
Hebrew (he)
Original Assignee
Regeneron Pharma
Sanofi Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2016/060344 external-priority patent/WO2017079443A1/en
Application filed by Regeneron Pharma, Sanofi Biotechnology filed Critical Regeneron Pharma
Publication of IL259064A publication Critical patent/IL259064A/en

Links

IL259064A 2015-11-03 2018-05-01 Compositions comprising il6r antibodies for the treatment of uveitis and macular edema and methods of using same IL259064A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562250269P 2015-11-03 2015-11-03
EP16306166 2016-09-14
US201662408391P 2016-10-14 2016-10-14
PCT/US2016/060344 WO2017079443A1 (en) 2015-11-03 2016-11-03 Compositions comprising il6r antibodies for the treatment of uveitis and macular edema and methods of using same

Publications (1)

Publication Number Publication Date
IL259064A true IL259064A (en) 2018-06-28

Family

ID=66624590

Family Applications (1)

Application Number Title Priority Date Filing Date
IL259064A IL259064A (en) 2015-11-03 2018-05-01 Compositions comprising il6r antibodies for the treatment of uveitis and macular edema and methods of using same

Country Status (3)

Country Link
IL (1) IL259064A (ru)
RU (1) RU2747193C2 (ru)
SG (1) SG10202004083UA (ru)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150050277A1 (en) * 2013-03-15 2015-02-19 Aerpio Therapeutics Inc. Compositions and methods for treating ocular diseases
JP6719384B2 (ja) * 2014-03-27 2020-07-15 ダイアックス コーポレーション 糖尿病黄斑浮腫の治療のための組成物および方法

Also Published As

Publication number Publication date
RU2747193C2 (ru) 2021-04-29
RU2018120106A3 (ru) 2020-03-05
SG10202004083UA (en) 2020-05-28
RU2018120106A (ru) 2019-12-05

Similar Documents

Publication Publication Date Title
ZA201907815B (en) Subcutaneous formulations of anti-cd38 antibodies and their uses
HRP20192145T1 (hr) Pripravci nosača-antitijela i metode pripreme i uporabe istih
IL272367A (en) Antibodies against CD39, compositions containing antibodies against CD39 and methods of using antibodies against CD39
DK3889145T3 (da) 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme
ZA201707303B (en) Compositions and methods for the treatment of immunodeficiency
SG11201803654TA (en) Compositions comprising il6r antibodies for the treatment of uveitis and macular edema and methods of using same
HK1259372A1 (zh) 治療化合物、其組合物及使用方法
ZA202104969B (en) Compositions comprising 15-hepe and methods of using the same
HK1247789A1 (zh) 用於治療水腫的組合物和方法
PT3204038T (pt) Composições que compreendem amilase para utilização no tratamento do prurido
ZA201902781B (en) Compositions and methods for the treatment of xerostomia
HK1247136A1 (zh) 包含15-hepe的組合物和其使用方法
HK1255695A1 (zh) 用於治療眼瞼下垂的組合物和方法
PL3113774T3 (pl) Kompozycje grapiprantu i sposoby ich zastosowania
IL251588A0 (en) Methods and preparations for increasing the potency of antifungal agents
IL259064A (en) Compositions comprising il6r antibodies for the treatment of uveitis and macular edema and methods of using same
EP3307903C0 (en) PROCESS FOR PREPARING KILLER-TOXINS